Covidien Receives U.S. FDA 510(k) Clearance for Reinforced Stapling Reload Technology

Covidien plc. (NYSE: COV ) announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the company's Endo GIA™ Reinforced Reload with Tri-Staple™ technology. This clearance extends Covidien's industry-leading portfolio of advanced surgical staplers and represents a return by the company to the U.S. market for